Health
Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection – News-Medical.Net
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine…
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.
Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection.
Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed…
-
Noosa News21 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News21 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
General17 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business21 hours ago16 ASX 200 shares roar to multi-year highs amid new market milestone